192 related articles for article (PubMed ID: 25769781)
1. Oncologic Outcomes of Penile Cancer Treatment at a UK Supraregional Center.
Veeratterapillay R; Teo L; Asterling S; Greene D
Urology; 2015 May; 85(5):1097-1103. PubMed ID: 25769781
[TBL] [Abstract][Full Text] [Related]
2. Lessons learnt in the management of primary invasive penile cancer in an Australian tertiary referral centre: clinical outcomes with a minimum 48 months follow-up study.
Chung E; Yang S; White L; Wood S; Nicol D
Korean J Urol; 2015 Feb; 56(2):125-30. PubMed ID: 25685299
[TBL] [Abstract][Full Text] [Related]
3. Contemporary management of penile cancer: greater than 15 year MSKCC experience.
Moses KA; Winer A; Sfakianos JP; Poon SA; Kent M; Bernstein M; Russo P; Dalbagni G
Can J Urol; 2014 Apr; 21(2):7201-6. PubMed ID: 24775572
[TBL] [Abstract][Full Text] [Related]
4. A 10-year retrospective audit of penile cancer management in the UK.
Mistry T; Jones RW; Dannatt E; Prasad KK; Stockdale AD
BJU Int; 2007 Dec; 100(6):1277-81. PubMed ID: 17850372
[TBL] [Abstract][Full Text] [Related]
5. Contemporary management of regional nodes in penile cancer-improvement of survival?
Djajadiningrat RS; Graafland NM; van Werkhoven E; Meinhardt W; Bex A; van der Poel HG; van Boven HH; Valdés Olmos RA; Horenblas S
J Urol; 2014 Jan; 191(1):68-73. PubMed ID: 23917166
[TBL] [Abstract][Full Text] [Related]
6. Organ-sparing surgery of penile cancer: higher rate of local recurrence yet no impact on overall survival.
Lindner AK; Schachtner G; Steiner E; Kroiss A; Uprimny C; Steinkohl F; Horninger W; Heidegger I; Madersbacher S; Pichler R
World J Urol; 2020 Feb; 38(2):417-424. PubMed ID: 31062123
[TBL] [Abstract][Full Text] [Related]
7. The Patterns of Practice and Outcomes of Penile Cancer in Ontario.
Mahmud A; Qu X; Yip D; Leveridge M; Mackillop W
Clin Oncol (R Coll Radiol); 2017 Apr; 29(4):239-247. PubMed ID: 28057403
[TBL] [Abstract][Full Text] [Related]
8. Intermediate-differentiated invasive (pT1 G2) penile cancer--oncological outcome and follow-up.
Schlenker B; Tilki D; Gratzke C; Seitz M; Reich O; Schneede P; Stief CG; Hungerhuber E
Urol Oncol; 2011; 29(6):782-7. PubMed ID: 19945307
[TBL] [Abstract][Full Text] [Related]
9. Penile cancer in the UK: clinical presentation and outcome in 1998/99.
Ritchie AW; Foster PW; Fowler S;
BJU Int; 2004 Dec; 94(9):1248-52. PubMed ID: 15610099
[TBL] [Abstract][Full Text] [Related]
10. The value of squamous cell carcinoma antigen in the prognostic evaluation, treatment monitoring and followup of patients with penile cancer.
Zhu Y; Ye DW; Yao XD; Zhang SL; Dai B; Zhang HL; Shen YJ
J Urol; 2008 Nov; 180(5):2019-23. PubMed ID: 18801542
[TBL] [Abstract][Full Text] [Related]
11. Surgical treatment of penile carcinoma: our experience from 1976 to 1997.
Ficarra V; D'Amico A; Cavalleri S; Zanon G; Mofferdin A; Schiavone D; Malossini G; Mobilio G
Urol Int; 1999; 62(4):234-7. PubMed ID: 10567891
[TBL] [Abstract][Full Text] [Related]
12. Recurrence patterns of squamous cell carcinoma of the penis: recommendations for follow-up based on a two-centre analysis of 700 patients.
Leijte JA; Kirrander P; Antonini N; Windahl T; Horenblas S
Eur Urol; 2008 Jul; 54(1):161-8. PubMed ID: 18440124
[TBL] [Abstract][Full Text] [Related]
13. EAU guidelines on penile cancer: 2014 update.
Hakenberg OW; Compérat EM; Minhas S; Necchi A; Protzel C; Watkin N
Eur Urol; 2015 Jan; 67(1):142-150. PubMed ID: 25457021
[TBL] [Abstract][Full Text] [Related]
14. Clinicopathologic Characteristics and Treatment Outcomes of Penile Cancer.
Nam JK; Lee DH; Park SW; Kam SC; Lee KS; Kim TH; Kim TS; Oh CK; Park HJ; Kim TN
World J Mens Health; 2017 Apr; 35(1):28-33. PubMed ID: 28459145
[TBL] [Abstract][Full Text] [Related]
15. Surgical treatment of invasive penile cancer--the Heidelberg experience from 1968 to 1994.
Brkovic D; Kälble T; Dörsam J; Pomer S; Lötzerich C; Banafsche R; Riedasch G; Staehler G
Eur Urol; 1997; 31(3):339-42. PubMed ID: 9129927
[TBL] [Abstract][Full Text] [Related]
16. Long-term followup of penile carcinoma with high risk for lymph node invasion treated with inguinal lymphadenectomy.
Marconnet L; Rigaud J; Bouchot O
J Urol; 2010 Jun; 183(6):2227-32. PubMed ID: 20399455
[TBL] [Abstract][Full Text] [Related]
17. Penile sparing surgery for penile cancer-does it affect survival?
Djajadiningrat RS; van Werkhoven E; Meinhardt W; van Rhijn BW; Bex A; van der Poel HG; Horenblas S
J Urol; 2014 Jul; 192(1):120-5. PubMed ID: 24373799
[TBL] [Abstract][Full Text] [Related]
18. Clinicopathologic characteristics and outcomes of penile cancer treated at tertiary care centers in the Western United States.
Jayaratna IS; Mitra AP; Schwartz RL; Dorff TB; Schuckman AK
Clin Genitourin Cancer; 2014 Apr; 12(2):138-42. PubMed ID: 24210829
[TBL] [Abstract][Full Text] [Related]
19. Organ-preserving surgery for penile cancer: description of techniques and surgical outcomes.
Veeratterapillay R; Sahadevan K; Aluru P; Asterling S; Rao GS; Greene D
BJU Int; 2012 Dec; 110(11):1792-5. PubMed ID: 22551234
[TBL] [Abstract][Full Text] [Related]
20. Penile cancer: about ten cases at the University Hospital of Rabat, review of the literature.
Slaoui A; Jabbour Y; El Ghazoui A; Karmouni T; Elkhader K; Koutani A; Attaya AI
Pan Afr Med J; 2015; 22():53. PubMed ID: 26664554
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
